Company Profile
Advanced Medical Strategies (AMS) is a healthcare technology company that helps health plans reduce unnecessary spend and improve payment accuracy across the full claims lifecycle.
AMS’s flagship platform, the Predict Suite, combines clinical standards of care with financial benchmarks, price transparency and payment integrity, along with an automated itemized bill review solution, giving payers the tools to identify overpayments, flag billing errors, reduce fiduciary liability and surface cost containment opportunities at scale.
Solutions include PredictPi, a robust, transparent payment integrity platform deployed by major health plans, and AI-Bill, an automated itemized bill review solution that uses advanced technology, machine learning and policy integration to automate the review of complex itemized bills in minutes.
The Goal
AMS works closely with healthcare payers to support cost containment and payment integrity strategies. Going into HPRI, part of the Medical Cost Containment Series (MCC), their focus was twofold: to generate new leads while also progressing existing conversations with large health plans that had stalled in the sales cycle.
Their priorities were:
- Engage new prospect accounts
- Re-engage key accounts in person
- Move beyond surface-level conversations
- Build stronger context around current payer priorities
AMS joined HPRI as a Headline Sponsor, with speaking opportunities, exhibition presence, 1:1 facilitated meetings, and delegate passes.
What Happened
Once onsite, AMS engaged senior stakeholders across both new and existing accounts in a focused, structured environment. The format of HPRI played a key role — the curated, facilitated meetings programme gave AMS direct access to senior decision-makers pre-qualified by the HPRI team. Based on a defined list of target companies and job titles, meetings were arranged in advance, helping ensure every interaction was relevant and commercially meaningful.
With senior payer and provider leaders in attendance, AMS used their speaking slots to position themselves as a credible voice in the space, contributing to discussions focused on real operational challenges rather than theory. Beyond the formal sessions, momentum continued throughout the event. Smaller group discussions, conversations at the AMS exhibition booth, and informal touchpoints created space for more candid, in-depth dialogue — which is often difficult to achieve at larger events.
The Outcome
The impact translated directly into measurable commercial outcomes. Following the event, AMS accelerated several high-value opportunities across both new and re-engaged accounts, including multiple seven-figure pursuits with large health plans. Total pipeline progressed: $2.7M+. These outcomes reflect deals already in motion that gained meaningful momentum through structured, inperson engagement. Additional pipeline from new connections made at the event is expected to convert in the months ahead.
These opportunities demonstrate how in-person engagement can accelerate deals already in motion.
